The Weight-Loss Pill Is Almost Here. What Oral GLP-1s Mean for the Future of Metabolic Medicine (opens in new tab)
A new phase 3 trial brings once-daily oral GLP-1 drugs a step closer to reality. Here’s what Orforglipron’s results actually show, and what questions remain.
Read the original article